Segall Bryant & Hamill’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,340
Closed -$833K 527
2023
Q2
$833K Buy
5,340
+250
+5% +$39K 0.01% 507
2023
Q1
$825K Sell
5,090
-1,000
-16% -$162K 0.01% 514
2022
Q4
$972K Hold
6,090
0.01% 491
2022
Q3
$857K Hold
6,090
0.01% 509
2022
Q2
$889K Sell
6,090
-300
-5% -$43.8K 0.01% 510
2022
Q1
$1.04M Buy
+6,390
New +$1.04M 0.01% 513
2021
Q4
Sell
-5,140
Closed -$1.04M 607
2021
Q3
$1.04M Hold
5,140
0.01% 525
2021
Q2
$1.04M Hold
5,140
0.01% 517
2021
Q1
$902K Hold
5,140
0.01% 566
2020
Q4
$873K Buy
5,140
+50
+1% +$8.49K 0.01% 490
2020
Q3
$826K Buy
5,090
+1,500
+42% +$243K 0.01% 479
2020
Q2
$585K Sell
3,590
-1,650
-31% -$269K 0.01% 555
2020
Q1
$670K Hold
5,240
0.01% 526
2019
Q4
$731K Hold
5,240
0.01% 589
2019
Q3
$617K Hold
5,240
0.01% 615
2019
Q2
$675K Sell
5,240
-200
-4% -$25.8K 0.01% 617
2019
Q1
$699K Hold
5,440
0.01% 604
2018
Q4
$602K Buy
5,440
+200
+4% +$22.1K 0.01% 615
2018
Q3
$713K Hold
5,240
0.01% 612
2018
Q2
$629K Buy
5,240
+500
+11% +$60K 0.01% 621
2018
Q1
$570K Buy
4,740
+240
+5% +$28.9K 0.01% 415
2017
Q4
$561K Buy
4,500
+200
+5% +$24.9K 0.01% 403
2017
Q3
$577K Hold
4,300
0.01% 404
2017
Q2
$540K Buy
4,300
+1,050
+32% +$132K 0.01% 418
2017
Q1
$387K Buy
3,250
+700
+27% +$83.4K 0.01% 445
2016
Q4
$274K Hold
2,550
0.01% 483
2016
Q3
$294K Hold
2,550
0.01% 477
2016
Q2
$261K Buy
+2,550
New +$261K 0.01% 493
2015
Q3
Sell
-1,500
Closed -$202K 547
2015
Q2
$202K Buy
+1,500
New +$202K ﹤0.01% 533